Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

CGEN-15001 is effective in an animal model of type 1 diabetes

Oct. 10, 2013

The Medicines Company and Alnylam to advance ALN-PCSsc

Oct. 10, 2013

Mileutis divulges peptides for lactation disorders

Oct. 10, 2013

Novel PCSK9 expression inhibitors described in Kowa patent

Oct. 10, 2013

Pfizer in-licenses preclinical program on early-onset morbid obesity

Oct. 9, 2013

Boost to MAX BioPharma's oxysterol program through licensing and SBIR grant

Oct. 9, 2013

Discovery of novel cathepsin K inhibitors for bone resorption

Oct. 9, 2013

First phase II results of a transdermal BA-058 microneedle patch for the treatment of osteoporosis

Oct. 9, 2013

FDA accepts IND application for LGD-6972 in type 2 diabetes

Oct. 8, 2013

Poxel reports data for imeglimin from human hyperglycemic clamp trial

Oct. 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...